Physician

Adil Ahmed, DO

According to 2025 Medicare claims, Adil Ahmed, DO (NPI: 1003372715) practices ophthalmology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS LLC (NPI: 1164578894; TIN: 208346981) and primary practice location at 07726-8274. Ahmed is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Ahmed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 441 traditional Medicare patients, billed 633 HCPCS/CPT codes, and received $55,506 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 330 prescription claims across 153 beneficiaries totaling $54,552 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 4 records totaling $79. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,172 to $54,552. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$28K$56K2023 Medicare payment: $8,173 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $55,506 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20236488$8,173
2024441633$55,506

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$27K$55K2020 Drug cost: $1,172 (USD; Tot_Drug_Cst)2021 Drug cost: $5,613 (USD; Tot_Drug_Cst)2022 Drug cost: $29,465 (USD; Tot_Drug_Cst)2023 Drug cost: $26,403 (USD; Tot_Drug_Cst)2024 Drug cost: $54,552 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201221$1,172
20211864$5,613
202278355$29,465
202392302$26,403
2024153330$54,552

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system5858$118
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more2837$108
92014Established patient complete exam of visual system181181$102
92012Established patient problem focused exam of visual system179251$70
92133Imaging of optic nerve1617$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine20840$16,630
XiidraLifitegrast12420$9,468
CombiganBrimonidine Tartrate/Timolol12371$2,799
Prednisolone AcetatePrednisolone Acetate562,152$2,256
MoxifloxacinMoxifloxacin Hcl43540$861

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$79Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adil Ahmed, DO?

Tedicare shows public-source Medicare data for Adil Ahmed, DO (NPI 1003372715), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adil Ahmed, DO have ACO affiliation data?

Adil Ahmed, DO is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Adil Ahmed, DO?

Adil Ahmed, DO is linked to ASSOCIATED RETINAL CONSULTANTS LLC (billing NPI 1164578894) in the available physician profile data.

Does Adil Ahmed, DO have Open Payments data?

Adil Ahmed, DO has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.